CELLULAR & MOLECULAR BIOLOGY LETTERS
Scope & Guideline
Transforming Knowledge in Biochemistry and Cell Biology
Introduction
Aims and Scopes
- Cancer Biology:
Research on the molecular mechanisms underlying cancer progression, including studies on tumor microenvironments, cancer stem cells, and therapeutic resistance. - Cellular Signaling and Regulation:
Exploration of signaling pathways involved in cellular processes such as proliferation, differentiation, and apoptosis, with implications for disease treatment. - Genomics and Epigenetics:
Investigation of genetic and epigenetic factors influencing cell behavior, including studies on non-coding RNAs, methylation patterns, and gene editing technologies. - Metabolic Disorders:
Research focused on the molecular basis of metabolic diseases, particularly how cellular metabolism affects disease progression and treatment responses. - Stem Cell Biology:
Studies on the mechanisms of stem cell differentiation, regeneration, and their roles in tissue repair and cancer. - Neurobiology and Neurodegenerative Diseases:
Investigations into the cellular and molecular underpinnings of neurological disorders, including studies on neuroinflammation and synaptic plasticity. - Innovative Therapeutics:
Research into novel therapeutic approaches, including the use of stem cells, exosomes, and CRISPR technologies for disease treatment.
Trending and Emerging
- RNA Modifications and Non-coding RNAs:
A surge in research on RNA modifications, particularly N6-methyladenosine (m6A), and the roles of non-coding RNAs in gene regulation and cancer biology is evident. - Targeted and Precision Medicine:
Emerging studies emphasize personalized therapeutic approaches, particularly in cancer treatment, through the use of biomarkers and tailored therapies. - Microbiome Influence on Disease:
Research increasingly explores how the microbiome affects cellular processes and disease outcomes, revealing significant interactions between gut health and systemic diseases. - Autophagy and Cellular Homeostasis:
There is a growing interest in the role of autophagy in maintaining cellular health and its implications for various diseases, including cancer and neurodegeneration. - CRISPR and Gene Editing Technologies:
The application of CRISPR and other gene-editing technologies continues to expand, influencing research in genetic diseases, cancer, and therapeutic innovations. - Cancer Immunotherapy:
Research on the mechanisms of immune evasion by tumors and the development of immunotherapeutic strategies is gaining momentum, reflecting the shift towards harnessing the immune system in cancer treatment. - Metabolic Reprogramming in Disease:
An increasing focus on how metabolic changes in cells contribute to disease progression, particularly in cancer and metabolic disorders, is becoming a prominent theme.
Declining or Waning
- Traditional Pharmacology:
Research that emphasizes conventional drug development and pharmacodynamics has seen a decline, with a shift towards more innovative and targeted therapeutic strategies. - Basic Cellular Mechanisms:
Studies solely focused on fundamental cellular processes without a clear application to disease or therapeutic relevance appear to be less frequent. - In vitro Studies without Translational Relevance:
There seems to be a decrease in in vitro studies that do not connect findings to potential clinical applications or translational research. - Animal Models with Limited Human Relevance:
Research utilizing animal models that do not effectively mimic human disease conditions is becoming less common, as the field emphasizes more relevant translational models.
Similar Journals
CYTOTECHNOLOGY
Advancing Cytotechnology: Pioneering Research for Tomorrow's Innovations.CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
Showcasing Breakthroughs in Cellular PhysiologyCellular Physiology and Biochemistry is a premier Open Access journal published by the prestigious Cell Physiol Biochem Press GmbH & Co, dedicated to advancing research in the fields of physiology, biochemistry, and molecular biology. Since its inception in 1987 and transitioning to an Open Access model in 2013, the journal has established itself as a vital resource for the dissemination of high-quality research and reviews, showcasing innovative methodologies and groundbreaking findings in cellular processes. With an impressive ranking in the 2023 Scopus category as Q2 in Physiology and a robust percentile of 61, Cellular Physiology and Biochemistry is committed to fostering academic dialogue among researchers, professionals, and students alike. This journal not only provides unrestricted access to its articles, but also promotes the global sharing of knowledge, which is essential for the advancement of our understanding in these vital scientific areas. The journal's editorial team is dedicated to ensuring the highest standards of academic rigor and relevance, making it an indispensable addition to the libraries of those engaged in the life sciences.
MOLECULAR AND CELLULAR BIOCHEMISTRY
Connecting Molecular Insights to Clinical ApplicationsMOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.
FEBS Journal
Your Gateway to Cutting-Edge Research in Life SciencesFEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.
DEVELOPMENTAL CELL
Pioneering Research in Cell and Developmental BiologyDEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.
Protein & Cell
Fostering Global Knowledge Exchange in Biochemical ResearchProtein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.
CELLULAR SIGNALLING
Pioneering Research in Cellular SignallingCELLULAR SIGNALLING, published by Elsevier Science Inc, is a premier journal within the realm of Cell Biology, boasting an impressive Q2 category ranking as of 2023. With an ISSN of 0898-6568 and an E-ISSN of 1873-3913, the journal has established itself as a critical platform for advancing the understanding of cellular mechanisms and signal transduction pathways since its inception in 1989. Covering a vast array of topics in Biochemistry, Genetics, and Molecular Biology, it ranks notably at 87 out of 285 in the Scopus list, placing it in the 69th percentile among its peers. The journal serves as an invaluable resource for researchers, professionals, and students seeking high-quality, impactful studies that drive forward the field of cellular biology. While it operates under traditional subscription access, its highlights include rigorous peer-reviewed articles, reviews, and insights that continue to shape current scientific discourse.
Genes & Diseases
Innovating solutions through genetic research and discovery.Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Fostering Collaboration in Life Sciences DiscoverySEMINARS IN CELL & DEVELOPMENTAL BIOLOGY is a premier journal published by Academic Press Ltd - Elsevier Science Ltd, focusing on the vital domains of cell and developmental biology. With an impact factor that reflects its rigorous contributions to the field, this journal embodies the highest standards of academic excellence, currently ranking in the Q1 quartile for both Cell Biology and Developmental Biology categories as of 2023. Researchers and practitioners will appreciate its robust Scopus ranking, placing it within the top tiers of developmental biology and cell biology, with percentile ranks of 94th and 90th respectively, showcasing the journal's influential presence in the scientific community. The journal aims to disseminate comprehensive reviews, cutting-edge research articles, and significant advances in the understanding of cellular mechanisms and developmental processes, thereby catering to a diverse audience that includes researchers, scholars, and students dedicated to the life sciences. Given its commitment to open access, SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY promotes widespread dissemination of knowledge, enhancing collaborative research efforts and driving innovation across biological disciplines.
Cell Discovery
Exploring the Depths of Biochemistry and GeneticsCell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.